Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CTNMCTNM
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CONTINEUM THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 497,255 shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $8.2M as of 2026-Q2. The position was increased (+61.9% shares). CTNM represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$8.2M

Current Shares

497,255

Total Value Change

+$7.8M

Total Shares Change

+470,890

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
497,255
+61.9%
$8.2M0.0%$16.39
40
2026-Q1
Increased
307,108
+190.8%
$4M0.0%$14.10
43
2025-Q4
Increased
105,594
+250.4%
$1.2M0.0%$11.40
41
2025-Q3
Decreased
30,135
-50.5%
$354,0860.0%$11.82
0
2025-Q2
Increased
60,922
+328.4%
$241,8600.0%$4.11
25
2025-Q1
Decreased
14,221
-46.1%
$99,2630.0%$7.07
0
2024-Q4
New
26,365
-
$386,2470.0%$14.47
33

Other major holders of CTNM: Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used